Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy
Autor: | Chuaypen, N., Posuwan, N., Chittmittraprap, S., Hirankarn, N., Treeprasertsuk, S., Tanaka, Y., Shinkai, N., Poovorawan, Y., Tangkijvanich, P. |
---|---|
Zdroj: | In Clinical Microbiology and Infection March 2018 24(3):306-306 |
Databáze: | ScienceDirect |
Externí odkaz: |